tion. In 1847, Dr. Ignaz Semmelweis, a Viennese physician, discovered that fatal infections were spread among patients by physicians who failed to wash their hands between examinations [2] . Semmelweis instituted a disinfecting procedure whereby physicians were required to wash in a chloride of lime solution after autopsies and with soap and water between patient visits. Doctors also had to change into clean coats before examining patients. As a result, hospital mortality rates from infectious diseases declined.
Handwashing by clinical staff is the single most important measure for preventing transmission of nosocomial infection. Today, handwashing should be a simple, standard antiseptic technique. However, studies conducted at hospitals worldwide have documented that compliance with handwashing is poor in the healthcare setting.
Since the late 1800s, when Lister promoted the application of carbolic acid to the hands of surgeons before procedures, preoperative cleansing of the hands and forearms with an antiseptic agent has been an accepted practice [3, 4] . In the next section, we review the evidence regarding antisepsis and decolonization of both patient and surgeon in efforts to prevent SSI.
GUIDELINES FOR SURGEON HAND ANTISEPSIS
The Centers for Disease Control and Prevention (CDC) Guideline for Handwashing and Environmental Control was first published in 1985 and provided basic recommendations for hand hygiene [5] . The subsequent comprehensive CDC Guideline for Hand Hygiene in Health-Care Settings, published in 2002, provides evidence-based recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the HIC-PAC/Society of Healthcare Epidemiologists of America (SHEA)/Association of Professionals in Infection Control (APIC)/Infectious Diseases Society of America (IDSA) Hand Hygiene Task Force [1] . A section on "Surgical Hand Antisepsis" was included, and the final recommendations are listed in Table 1 .
The Guideline for the Prevention of Surgical Site Infection [6] , published in 1999, is an evidence-based comprehensive summary issued by the CDC and HICPAC. A summary and review of these evidence-based guidelines was also published, and summary recommendations for patient and surgeon antisepsis were provided (Table 2 ) [7] . In 2002, the CDC MMWR (Morbidity and Mortality Weekly Report) Guideline for Hand Hygiene in the Healthcare Setting 10-25-2002 recommended that "Surgical hand antisepsis using either an antimicrobial soap (2-5 min scrub) or an alcohol-based handrub with persistent activity is recommended before donning sterile gloves when performing surgical procedures (Category 1B recommendation). 
ISSUES IN SURGICAL HAND HYGIENE AND ANTISEPSIS
Perioperative surgical hand hygiene is a complex issue. The usual surgical antisepsis involves scrubbing the skin with antiseptic solutions. This procedure can damage the skin, with a paradoxical subsequent higher risk of infection for the patient. There now are several efficient and quick-acting antiseptic alcohol solutions that require no scrubbing. Because of their efficacy, persistent effect, and skin protection, many experts have advised that classi- Remove rings, watches, and bracelets before beginning the surgical hand scrub (Category II). Remove debris from underneath fingernails using a nail cleaner under running water (Category II). Surgical hand antisepsis using either an antimicrobial soap or an alcohol-based hand rub with persistent activity is recommended before donning sterile gloves when performing surgical procedures (Category IB). When performing surgical hand antisepsis using an antimicrobial soap, scrub hands and forearms for the length of time recommended by the manufacturer, usually 2-6 min. Long scrub times (e.g., 10 min) are not necessary (Category IB). When using an alcohol-based surgical hand-scrub product with persistent activity, follow the manufacturer's instructions. Before applying the alcohol solution, wash hands and forearms with a non-antimicrobial soap and dry them completely. After application of the alcohol-based product as recommended, allow hands and forearms to dry thoroughly before donning sterile gloves (Category IB)
From reference 4. 
Preparation of the patient
Category 1A Identify and treat all infections remote from the surgical site before elective operations; postpone operation until infection has resolved Do not remove hair unless it is at or near the incision site and will interfere with surgery.
If hair is removed, this should be done immediately beforehand, preferably with electric clippers. Category 1B
Control the blood glucose concentration in all diabetic patients and avoid hyperglycemia perioperatively Encourage abstinence from tobacco for a minimum of 30 days before surgery Do not withhold indicated blood donations as a means to prevent SSI Patients should shower or bathe with an antiseptic solution at least the night before surgery Wash and clean the incision site to remove gross skin contamination prior to the antiseptic skin preparation with an appropriate agent Category 2
Prepare area by application of the antiseptic agent in concentric circles. The prepared area should be large enough to accommodate any necessary drains or stomas. Keep the preoperative hospital stay as short as possible consistent with adequate preparation for surgery
Hand/forearm antisepsis
Category 1B Keep nails short; do not wear artificial nails Scrub the hands and forearms up to the elbows for at least 2 to 5 min with an appropriate antiseptic After the scrub, keep hands and arms up and away from the body so that water runs from the fingertips to the elbows. Dry with a sterile towel before donning sterile gown and gloves Category 2
Clean under each fingernail before the first scrub of the day Unresolved:
There is no recommendation regarding the wearing of nail polish
Infected/colonized surgical personnel
Category 1B Educate and encourage personnel with signs and symptoms of a transmissible infectious disease to report it promptly to supervisors and occupational health officials Develop and maintain policies regarding patient-care responsibilities when personnel have potentially transmissible infections Obtain cultures from and exclude from duty personnel with draining skin lesions until infection is ruled out or the lesion has responded to anti-infective therapy Do not routinely exclude from patient care those personnel colonized with organisms such as Staphylococcus aureus or group A streptococci unless an epidemiologic link with dissemination has been established
Antimicrobial prophylaxis
Category 1A Administer antibiotic prophylaxis only when indicated and only when efficacious against the pathogens most commonly causing SSI for the particular operation Administer initial dose intravenously, timed such that a bactericidal concentration of the drug is present in the serum and tissues when the incision is made. Maintain therapeutic concentrations of the agent in the serum and tissues for the duration of the operation. Therapeutic levels should be maintained at most only until a few hours after the incision is closed Before elective colon operations, prepare the colon mechanically with enemas or cathartic agents. Administer nonabsorbable oral antimicrobial agents in multiple doses on the day before surgery For high-risk cesarian section, administer the prophylactic antibiotic agent immediately after the umbilical cord is clamped Category 1B Do not use vancomycin routinely for surgical prophylaxis
Surgical attire and drapes
Category 1B Wear surgical mask to cover the mouth and nose fully for the duration of the operation or while sterile instruments are exposed* Wear a cap or hood so as to cover all hair on head and face fully* Wear sterile gloves after a sterile gown is donned (all scrubbed surgical team members)* Do not wear shoe covers for the prevention of SSI* The surgical gowns and drapes used should be effective barriers when wet Change scrub suits that are visibly soiled or contaminated by blood or other potentially infectious materials (continued) cal scrubbing with antiseptic solutions be replaced with gentle washing with a waterless alcohol solution [9] . The introduction of waterless, scrubless alcohol-based hand antiseptics into the operating room, where traditional scrubbing has been the standard, requires education for proper application and initiation of programs to monitor methodology and compliance. The integration of these rinseless products has been challenging. Contributing to the confusion is the U.S. Food and Drug Administration (FDA) statement that products considered to be surgical scrubs must show characteristics that include immediate microbial killing, broad-spectrum activity, and persistence of the effect for as long as six hours.
One of the largest surgical antisepsis studies compared hand rubbing with aqueous alcohol (75% aqueous alcoholic solution containing propanol-1, propanol-2, and mecetronium etilsulfate) with traditional scrubbing with an antiseptic preparation containing 4% povidoneiodine or 4% chlorhexidine gluconate. A total of 4,387 consecutive patients who underwent clean and clean-contaminated surgery were studied in a randomized equivalence trial [10] . The 30-day SSI rates were 55 of 2,252 (2.44%) with the hand-rubbing protocol and 53 of 2,135 (2.48%) with the hand-scrubbing protocol, for a difference of 0.04% (95% confidence interval, -0.88%, 0.96%) ( Table 3) . Compliance with the recommended duration of hand antisepsis was better in the hand-rubbing than the handscrubbing protocol (44% vs. 28%, respectively; p ϭ 0.008), as was tolerance, with less skin dryness and irritation after aqueous alcohol use. Hand rubbing with aqueous alcoholic solution, preceded by a 1-min nonantiseptic hand wash before each surgeon's first procedure of the day and before any procedure if the hands were soiled, was as effective as traditional hand scrubbing in preventing SSIs. The hand-rubbing protocol was tolerated better by the surgical teams and improved compliance with hygiene guidelines, leading to the conclusion that
Unresolved
No recommendations are made about restricting scrub suits to the operating suite or covering them when out of the suite
Asepsis and surgical technique
Category 1A Adhere to principles of asepsis when placing intravascular devices or when dispensing or administering intravenous drugs Category 1B
Handle tissue gently, maintain hemostasis, minimize devitalized or charred tissue and foreign bodies, and eradicate dead space at the surgical site Use delayed primary skin closure or allow incisions to heal by secondary intention if the surgical site is contaminated or dirty Use closed suction drains when drainage is necessary, placing the drain through a separate incision distant from the operative incision. Remove drains as soon as possible Category 2
Assemble sterile equipment and solutions immediately prior to use
Postoperative incision care
Category 2 Keep a sterile dressing for 24 to 48 h postoperatively on an incision closed primarily.
No recommendation is made regarding keeping a dressing on the wound beyond 48 h or for bathing and showering after the bandage is removed Wash hands before and after changing dressings and any contact with the surgical site. Use sterile technique to change dressings Educate the patient about SSI, relevant symptoms and signs, and the need to report them if noted Unresolved
No recommendation is made with respect to keeping an incision covered for more than 48 h *Regulated by the U.S. Occupational Health and Safety Administration. Recommendations for intraoperative ventilation, cleaning and disinfection of environmental surfaces, sterilization of surgical instruments, epidemiologic investigations in the operating room, and surveillance may be found in the source document.
SSI ϭ surgical site infection.
Modified from reference 1. hand rubbing with a liquid aqueous alcoholic solution can be used safely for preoperative hand hygiene. In another study [11] , a comparison of five protocols for surgical handwashing confirmed that the alcohol-based antiseptics were associated with significantly lower numbers of colony-forming units in two of the three postscrub samples (p ϭ 0.003, p ϭ 0.035). The five study protocols were: (1) An initial scrub of 5 min and consecutive scrubs of 3.5 min with 4% chlorhexidine gluconate; (2) an initial scrub of 3 min and consecutive scrubs of 2.5 min with 4% chlorhexidine gluconate; (3) an initial scrub of 3 min and consecutive scrubs of 2.5 min with 5% povidone-iodine and 1% triclosan; (4) an initial scrub of 2 min with 4% chlorhexidine gluconate followed by a 30 sec application of 70% isopropyl alcohol and 0.5% chlorhexidine gluconate, and a 30 sec application of 70% isopropyl alcohol and 0.5% chlorhexidine gluconate for consecutive scrubs; (5) an initial scrub of 2 min with 4% chlorhexidine gluconate followed by a 30 sec application of 70% ethanol and 0.5% chlorhexidine gluconate, and a 30 sec application of 70% ethanol and 0.5% chlorhexidine gluconate for consecutive scrubs. A scrub protocol using alcohol-based antiseptics was as effective as and no more damaging to skin than more time-consuming conventional methods using detergent-based antiseptics.
Similarly, Kac et al. [12] found that hand rubbing with an alcohol-based solution produced a significantly greater reduction in microbiological load than handwashing with unmedicated soap (p Ͻ 0.0001 for palms and p ϭ 0.0003 for fingertips). After hand rubbing, no transient pathogens were recovered, whereas pathogens were recovered after handwashing in two cases. This study also confirmed that rubbing was more efficacious than washing for the decontamination of healthcare workers' hands after contact with patients and patient environments [12] . Handrubbing with an alcohol-based solution also is significantly more efficient in reducing hand contamination than washing with an antiseptic soap [13, 14] . Furthermore, it has been recognized that an alcohol-based hand antiseptic used in conjunction with a scrub agent (i.e., after a brief surgical scrub) enhances the effectiveness of decontamination [15] .
Additional studies have documented that hand antisepsis with an alcoholic gel regimen is well tolerated and does not cause skin irritation and dryness. In contrast, skin irritation and dryness increased significantly when washing with the unmedicated soap product. Newer alcoholic hand gels that are less irritating than soap may be more acceptable to staff and lead to better hand-hygiene practices [16, 17] .
Chlorhexidine gluconate and alcohol gel as disinfectants were compared in a randomized trial involving orthopedic surgeons [18] . The hand-washing protocol dictated that all surgeons wash for 5 min with chlorhexidine before their first case. Thereafter, the surgeon was randomized to wash for 3 min with either alcohol gel or chlorhexidine. At the end of each procedure, the gloves were removed, and an impression of the surgeon's fingertips was made on an agar plate. The numbers of bacterial colonies present after 24 h and 48 h of incubation were recorded for each agar plate by a microbiologist unaware of the washing protocol. Overall, 41 procedures and 82 episodes of hand washing were studied. Four hands (8%) were contaminated in the chlorhexidine group compared with 19 (34%) in the alcohol teristics, efficacy, and appropriate indications of these products is necessary for all practicing surgeons. The microbiologic activities and potential uses of these antiseptics are provided in detail in Table 5 .
An alcohol-based product that could be used to decontaminate the hands with or without water (i.e., water optional) while providing immediacy of killing and persistence could reduce the confusion associated with the national handwashing guidelines [19] . Such a product has been developed. Triseptin (Healthpoint, Inc., Fort Worth, TX), which is alcohol-based (61%) and zinc pyrithione (ZPT)-preserved, is compliant with the FDA and CDC guidelines. The 61% alcohol-ZPT product easily produced Ͼ3.0 log 10 reductions in the indicator strain (Serratia marcescens) with the first wash, exceeding the 2.0 log 10 FDA requirement. This level of performance was maintained through the tenth wash, surpassing the 3.0 log 10 FDA requirement for the handwash indication. For the assessment of persistence and residual effect in the waterless mode, the water-optional, 61% alcohol-ZPT product consistently produced log 10 reductions of 3.5 or greater at every point over the entire study period. In the water-aided configuration, similar results were obtained, as log 10 reductions of 2.5 were observed. The formulation was non-irritating, actually improving hand skin condition. The 61% alcohol-ZPT product therefore exceeded all FDA criteria for the health care personnel handwash indication and is a substantial advancement in the concept of skin antisepsis in that it is a single product suitable for all handhygiene settings and demonstrates better antimicrobial persistence and residual effects. A previously reported study has documented it to be virucidal for several DNA and RNA viruses [20] .
PREOPERATIVE BATHING OR SHOWERING WITH SKIN ANTISEPTICS TO PREVENT SSI
Preoperative bathing or showering with an antiseptic skin wash product is a well-accepted and commonly recommended procedure for reducing skin bacteria and microflora prior to surgery. The CDC Guideline for the Prevention of Surgical Site Infection now "strongly recommends" (Category IB) that healthcare facilities "require patients to shower or bathe with an antiseptic agent on at least the night before the operative day," as a preoperative antiseptic shower or bath decreased skin microbial colony counts ninefold in the studies they cite. Although the CDC cautions that the showers have not been shown definitively to reduce SSI rates, the practice is sound as it relates to skin microbiology, given the fact that the majority of SSIs are associated with skin flora.
A recent Cochrane systematic review examined six trials of preoperative bathing involving a total of 10,007 participants [21] . The antiseptic used in all trials was 4% chlorhexidine gluconate. Bathing with chlorhexidine com- 
CHARACTERISTICS, EFFICACY, AND INDICATIONS FOR VARIOUS CLASSES OF TOPICAL SKIN ANTISEPTICS (CONT'D)

Characteristics Efficacy Indications
Abbreviations: RSV ϭ respiratory syncytial virus; HBV ϭ hepatitis B virus; HCV ϭ hepatitis C virus; HIV ϭ human immunodeficiency virus; CMV ϭ cytomegalovirus; ED ϭ emergency department; ICU ϭ intensive care unit; FDA ϭ U.S. Food and Drug Administration. 
ANTISEPSIS OF THE SURGICAL SITE
Antiseptic preoperative skin site cleansing is used to prepare the operative site before making a surgical incision. The goal is a reduction in postoperative SSI. The usual method is scrubbing the skin with an antiseptic, traditionally povidone-iodine solution. Just as with surgeon hand hygiene, this procedure can damage the skin, possibly increasing the risk of infection. There are several efficient and quickacting antiseptic alcohol solutions that require 
Spectrum of activity
no scrubbing. The traditional preoperative practice is increasingly being replaced by chlorhexidine, which, unlike povidone-iodine, remains active in the presence of blood and serum. One application of chlorhexidine exceeds the FDA criteria for antisepsis in preoperative patient skin preparation. ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol; Medi-Flex, Inc., Leawood, KS) was superior to DuraPrep (0.7% iodine and 74% isopropyl alcohol; 3M Corp., St. Paul, MN) and Techni-Care (3.0% chloroxylenol; CareTech Laboratories, St. Louis, MO) in eliminating bacteria in a prospective study of 125 consecutive patients undergoing surgery of the foot and ankle [22] . These findings were confirmed in a randomized study [23] .
It is crucially important to educate healthcare practitioners in the proper method of application of chlorhexidine solution, which should be scrubbed on for 30 sec in a back-and-forth motion, the friction of which is part of what makes the solution effective. The area does not need be doused or flooded with this agent, as some do with povidone-iodine solution. Scrubbing it on to cover the intended area is sufficient. The prepared area must then be allowed to dry completely, and the solution should not be blotted or wiped away. The preparation contains alcohol; therefore, adequate drying is also important for the prevention of fires caused by electrocautery. One previous difficulty with chlorhexidine skin preparations was the inability to discern that all areas of the skin had been covered, because the solution was colorless. A teal-colored tint has now been added for easier visibility.
If povidone-iodine skin preparation is to be used, there is still the question of whether scruband-paint vs. paint alone is superior. A randomized trial in 240 patients undergoing nonlaparoscopic abdominal operations compared a vigorous 5-minute scrub with povidone-iodine soap followed by absorption with a sterile towel and painting with aqueous povidone-iodine (n ϭ 115) with site preparation with povidoneiodine paint only (n ϭ 119) [24] . The primary endpoint was the 30-day SSI rate, defined as the presence of clinical signs of infection necessitating therapeutic intervention. The patients in the two groups were well matched with respect to age, co-morbidity, wound classification, mean operative time, placement of drains, prophylactic antibiotic use, and surgical procedure (all p Ͼ 0.09). Surgical site infection occurred in 12 (10%) scrub-and-paint patients and 12 (10%) paintonly patients. According to the predefined parameters, these results were equivalent, suggesting that preoperative preparation of the abdomen with a povidone-iodine soap scrub and painting with aqueous povidone-iodine can be abandoned in favor of painting alone. However, this trial had a small sample size, and validation of the findings is warranted.
SKIN ANTISEPSIS IN CLEAN SURGERY
It is unclear whether preoperative skin antisepsis actually reduces SSI in clean surgery. A Cochrane review that examined this issue concluded that there is insufficient evidence that cleaning patients' skin with antiseptic before clean surgery reduces SSI [25] . Six eligible randomized controlled trials evaluated antiseptics applied immediately prior to incision in clean surgery. There was significant heterogeneity in the design of studies, however, and the results could not be pooled. In one of these studies, infection rates were significantly lower when skin was prepared using chlorhexidine rather than iodine. There was no evidence of a benefit in four trials that examined the use of iodophor-impregnated drapes.
A recent prospective cohort study compared SSI rates of 905 control patients who underwent skin preparation with normal saline compared with 905 patients for whom either chlorhexidine or povidone-iodine skin preparation was used. In both patient groups, a preoperative shower of the surgical site with soap and water was required. There were no SSIs in any group [26] .
STAPHYLOCOCCUS AUREUS NASAL DECOLONIZATION FOR PREVENTION OF SSI
Staphylococcus aureus remains the most common cause of SSI. The ecologic niche of S. aureus is the anterior nares, and nasal colonization by the organism is common. Approximately one-third of humans have skin and mucosal colonization by S. aureus, although most never become ill as a result. However, carriers are at higher risk for staphylococcal infections after invasive medical or surgical procedures than are non-carriers [27, 28] .
Decolonization, the use of antibiotics or antiseptics to reduce the magnitude of the reservoir in colonized patients, may be a useful undertaking. Several studies have reported lower rates of SSI among colonized patients who received 2% mupirocin ointment to the nares than among historical control subjects [29] [30] [31] , although there is no benefit to the use of mupirocin for non-colonized patients.
A large randomized, double-blind, placebocontrolled trial (the Mupirocin and the Risk of Staphylococcus aureus -MARS -Study) examined whether preoperative nasal decolonization with mupirocin would decrease the rate of S. aureus SSI [32] . Overall, 2.3% of mupirocin recipients and 2.4% of the placebo recipients had S. aureus SSIs among the 3,864 patients in the intent-to-treat analysis, who underwent general, gynecologic, neurologic, or cardiothoracic surgery. Thus, prophylactic intranasal application of mupirocin did not significantly reduce the rate of S. aureus SSIs [32] . Interestingly, it did decrease significantly the rate of all nosocomial S. aureus infections among the patients who were carriers (4.0% vs. 7.7%; odds ratio [OR] 0.49; 95% CI, 0.25, 0.92; p ϭ 0.002).
Another randomized study in 395 digestive surgery patients compared intranasal mupirocin 30 mg TID preoperatively for three days with no drug [33] . There were 21 gram-positive SSIs, 10 in the treated group and 11 in the control patients. Thus, intranasal mupirocin treatment had no significant impact on SSI after digestive surgery. However, this study did identify a significant reduction in the incidence of postoperative pneumonia, with none in the mupirocintreated group and five in control patients (p ϭ 0.028), with MRSA being the causative pathogen in four of the latter five patients.
DECOLONIZATION OF COLONIZED PATIENTS
A number of surgical patients are colonized with antibiotic-resistant pathogens, particularly methicillin-resistant S. aureus (MRSA), in the preoperative period and therefore are at higher risk for SSI with these pathogens. Consensus regarding the optimal preoperative preparation of MRSA-colonized patients, and whether preoperative decolonization should be attempted, has not been achieved. Furthermore, the optimal antimicrobial or antiseptic agents to use for prophylaxis in these colonized patients have not been determined.
A number of studies have documented a reduction in SSI with decolonization, but most were not randomized and controlled [30, 34, 35] . Topical perioperative prophylaxis for prevention of MRSA SSIs was examined using a controlled before-after approach on patients undergoing insertion of metal orthopedic prostheses or fixation. Patients received perioperative prophylaxis with nasal mupirocin ointment for five days and a shower or bath with 2% triclosan before surgery. Patients were followed for 12 months postoperatively. After introduction of the decolonization regimen, there was a marked decrease in the incidence of MRSA SSIs, from 23 per 1000 operations in the six months before the regimen to 3.3 (p Ͻ 0.001) and 4 (p Ͻ 0.001) in subsequent consecutive six-month periods. Point prevalence nasal carriage of MRSA decreased from 38% before the decolonization regimen was initiated to 23% immediately after, and 20%, 7%, 10%, and 8% (p Ͻ 0.001) at six-monthly intervals post-intervention [36] . Low-level mupirocin resistance was identified in 2.3% of S. aureus isolates from patients before the decolonization regimen was initiated and in 3.9%, 6.1%, 10%, and 0% in subsequent six-month periods. Furthermore, no S. aureus strains with high-level mupirocin resistance were isolated. The study investigators concluded that this regimen could reduce the incidence of MRSA SSI after orthopedic surgery, probably by reducing endemic nasal MRSA carriage, without selecting for mupirocin resistance. On the other hand, a randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of MRSA suggested that nasal mupirocin was only marginally effective in the eradication of multi-site MRSA carriage in a setting where MRSA was endemic [37] . The SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus (May 2003) can be found in Table 6 [38 -47] . Similarly, the Guidelines for the Con-trol and Prevention of MRSA in Healthcare Facilities, published by the Joint Working Party of the British Society of Antimicrobial Chemotherapy, the Hospital Infection Society, and the Infection Control Nurses Association [48] recently published recommendations regarding decolonization (Table 7) .
A Cochrane review examined all randomized, controlled trials of MRSA-colonized patients who were decolonized with topical or systemic antimicrobials or given a placebo or no treatment, as well as trials that compared combinations of single topical or systemic agents with no treatment, placebo, or topical or systemic agents [49] . Six trials (384 participants) met the inclusion criteria. No difference in MRSA eradication was detected in four studies: One that compared mupirocin with placebo, two that compared one systemic agent with no treatment (fusidic acid in one and rifampin or minocycline in the other), and one that compared mupirocin with topical fusidic acid and oral trimethoprim-sulfame-thoxazole. One study compared minocycline with rifampin, with rifampin being more effective in the eradication of MRSA from all sites at day 30 (RR 0.16; 95% CI 0.02, 1.00), but there was no difference at 90 days. Two studies (one testing novobiocin and rifampin, the other cipro-floxacin and rifampin, versus trimethoprim-sulfamethoxazole and rifampin) demonstrated no difference in eradication of MRSA at all sites (n ϭ 94). Adverse events occurred in as many as 20% of participants receiving systemic agents; however, event reporting was sporadic, and denominators were small. All trials detected development of resistance to antimicrobial agents used. The conclusion is that there is insufficient evidence to support use of topical or systemic antimicrobials for eradicating nasal or extra-nasal MRSA, and there is no demonstrated superiority of either topical or systemic therapy, or of combinations of these agents, yet potentially serious adverse events and antimicrobial resistance can result.
Another guideline, the North Carolina Guidelines for Control of Antibiotic-Resistant Organisms [50] , states: "Routine decolonization for MRSA is not recommended. The need for decolonization should be based on the patient's medical condition and expected outcome. Topi- 
Nasal decolonization
Patients receiving prophylaxis for an operative procedure and in an outbreak situation under the advice of the infection control team should undergo nasal decolonization. This should be undertaken by applying mupirocin 2% in a paraffin base (ointment) to the inner surface of each nostril (anterior nares) three times daily for five days. The patient should be able to taste mupirocin at the back of the throat after application (Category 1B). Mupirocin should not be used for prolonged periods or used repeatedly (i.e., for more than two courses for five days), as resistance may be encouraged (Category 1A). The presence of a foreign body such as a nasogastric tube may reduce the efficacy of treatment with nasal mupirocin (Category 2). Nasal decolonization using topical nasal mupirocin should be used with other forms of intervention such as skin decolonization with 4% chlorhexidine gluconate aqueous solution (Category 2).
Skin decolonization
Skin decolonization using 4% chlorhexidine bodywash/shampoo, 7.5% povidone-iodine or 2% triclosan is useful in eradicating or suppressing skin colonization for short times, particularly preoperatively to reduce the risk of SSIs (Category 1A). Patients should bathe daily for five days with the chosen antiseptic detergent. The skin should be moistened and the antiseptic detergent should be applied thoroughly to all areas before rinsing in the bath or shower. Special attention should be paid to known carriage sites such as the axilla, groin and perineal area. The antiseptic should also be used for all other washing procedures and for bed bathing.
Hair should be washed with antiseptic detergent (Category 1A). After satisfactory completion of a course of treatment, clean clothing, bedding and towels should be provided after each bath and hairwash (Category 2).
MRSA ϭ methicillin-resistant Staphylococcus aureus. cal or systemic antibiotics, including trimethoprim-sulfamethoxazole, rifampin, ciprofloxacin, erythromycin, doxycycline, bacitracin, and mupirocin have been used with variable results to eradicate colonization by MRSA. Vancomycin is not indicated for decolonization therapy, as it is ineffective for this purpose. There is no clinically proven decolonization regimen for vancomycin-resistant enterococci (VRE)."
